| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1174435
[patent_doc_number] => 06750324
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-15
[patent_title] => 'Humanized and chimeric N-terminal amyloid beta-antibodies'
[patent_app_type] => B1
[patent_app_number] => 09/724552
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 25
[patent_no_of_words] => 43986
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/750/06750324.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724552
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724552 | Humanized and chimeric N-terminal amyloid beta-antibodies | Nov 27, 2000 | Issued |
Array
(
[id] => 1131559
[patent_doc_number] => 06787637
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-07
[patent_title] => 'N-Terminal amyloid- antibodies'
[patent_app_type] => B1
[patent_app_number] => 09/724551
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 25
[patent_no_of_words] => 43959
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/787/06787637.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724551
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724551 | N-Terminal amyloid- antibodies | Nov 27, 2000 | Issued |
Array
(
[id] => 1017643
[patent_doc_number] => 06890535
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-10
[patent_title] => 'Pharmaceutical compositions and methods for treatment of amyloid diseases'
[patent_app_type] => utility
[patent_app_number] => 09/724567
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 22
[patent_no_of_words] => 41987
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/890/06890535.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724567
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724567 | Pharmaceutical compositions and methods for treatment of amyloid diseases | Nov 27, 2000 | Issued |
| 09/708096 | Beta secretase transgenic organisms and methods of use thereof | Nov 2, 2000 | Abandoned |
| 09/702021 | Fail molecules and uses thereof | Oct 29, 2000 | Abandoned |
| 09/529296 | Interferon-gamma regulatory factors | Oct 19, 2000 | Abandoned |
Array
(
[id] => 1068622
[patent_doc_number] => 06844148
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-01-18
[patent_title] => 'Alzheimer\'s disease secretase, APP substrates therefor, and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 09/668314
[patent_app_country] => US
[patent_app_date] => 2000-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 34821
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/844/06844148.pdf
[firstpage_image] =>[orig_patent_app_number] => 09668314
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/668314 | Alzheimer's disease secretase, APP substrates therefor, and uses therefor | Sep 21, 2000 | Issued |
| 09/658912 | Guided development and support of hydrogel-cell compositions | Sep 10, 2000 | Abandoned |
Array
(
[id] => 990550
[patent_doc_number] => 06919075
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-07-19
[patent_title] => 'Bacteriophage displaying aβ epitopes and method of use'
[patent_app_type] => utility
[patent_app_number] => 09/830954
[patent_app_country] => US
[patent_app_date] => 2000-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 49
[patent_no_of_words] => 25323
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/919/06919075.pdf
[firstpage_image] =>[orig_patent_app_number] => 09830954
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/830954 | Bacteriophage displaying aβ epitopes and method of use | Aug 30, 2000 | Issued |
Array
(
[id] => 1012590
[patent_doc_number] => 06897061
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-24
[patent_title] => 'Transdifferentiation of glial cells'
[patent_app_type] => utility
[patent_app_number] => 09/644498
[patent_app_country] => US
[patent_app_date] => 2000-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5858
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/897/06897061.pdf
[firstpage_image] =>[orig_patent_app_number] => 09644498
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/644498 | Transdifferentiation of glial cells | Aug 22, 2000 | Issued |
Array
(
[id] => 1228469
[patent_doc_number] => 06696409
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-24
[patent_title] => 'Neuropeptide Y agonists'
[patent_app_type] => B1
[patent_app_number] => 09/641567
[patent_app_country] => US
[patent_app_date] => 2000-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6842
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/696/06696409.pdf
[firstpage_image] =>[orig_patent_app_number] => 09641567
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/641567 | Neuropeptide Y agonists | Aug 17, 2000 | Issued |
Array
(
[id] => 7612767
[patent_doc_number] => 06903068
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-06-07
[patent_title] => 'Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines'
[patent_app_type] => utility
[patent_app_number] => 09/641801
[patent_app_country] => US
[patent_app_date] => 2000-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 21
[patent_no_of_words] => 10494
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/903/06903068.pdf
[firstpage_image] =>[orig_patent_app_number] => 09641801
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/641801 | Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines | Aug 16, 2000 | Issued |
Array
(
[id] => 1059595
[patent_doc_number] => 06852685
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-08
[patent_title] => 'Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation'
[patent_app_type] => utility
[patent_app_number] => 09/641802
[patent_app_country] => US
[patent_app_date] => 2000-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6021
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852685.pdf
[firstpage_image] =>[orig_patent_app_number] => 09641802
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/641802 | Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation | Aug 16, 2000 | Issued |
| 09/628495 | Compositions kits and methods for prognostication, diagnosis, prevention,and treatment of bone-related disorders and other disorders | Jul 27, 2000 | Abandoned |
Array
(
[id] => 1192064
[patent_doc_number] => 06730301
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-04
[patent_title] => 'MCP-1 receptor antibodies'
[patent_app_type] => B1
[patent_app_number] => 09/625573
[patent_app_country] => US
[patent_app_date] => 2000-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21182
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/730/06730301.pdf
[firstpage_image] =>[orig_patent_app_number] => 09625573
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/625573 | MCP-1 receptor antibodies | Jul 24, 2000 | Issued |
| 09/620955 | Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders | Jul 20, 2000 | Abandoned |
| 09/615220 | Methods and materials relating to soluble immunoglobulin E receptor alpha chain-like polypeptides and polynucleotides | Jul 12, 2000 | Abandoned |
Array
(
[id] => 985236
[patent_doc_number] => 06923964
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-08-02
[patent_title] => 'Active immunization of AScr for prion disorders'
[patent_app_type] => utility
[patent_app_number] => 09/585817
[patent_app_country] => US
[patent_app_date] => 2000-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 23
[patent_no_of_words] => 41982
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/923/06923964.pdf
[firstpage_image] =>[orig_patent_app_number] => 09585817
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/585817 | Active immunization of AScr for prion disorders | May 31, 2000 | Issued |
Array
(
[id] => 996306
[patent_doc_number] => 06913745
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-07-05
[patent_title] => 'Passive immunization of Alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 09/979952
[patent_app_country] => US
[patent_app_date] => 2000-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 23
[patent_no_of_words] => 41960
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/913/06913745.pdf
[firstpage_image] =>[orig_patent_app_number] => 09979952
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/979952 | Passive immunization of Alzheimer's disease | May 31, 2000 | Issued |
Array
(
[id] => 1154294
[patent_doc_number] => 06761888
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-13
[patent_title] => 'Passive immunization treatment of Alzheimer\'s disease'
[patent_app_type] => B1
[patent_app_number] => 09/580018
[patent_app_country] => US
[patent_app_date] => 2000-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 25
[patent_no_of_words] => 43836
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/761/06761888.pdf
[firstpage_image] =>[orig_patent_app_number] => 09580018
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/580018 | Passive immunization treatment of Alzheimer's disease | May 25, 2000 | Issued |
